Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Affron EYE is a **nutraceutical saffron extract ingredient** developed by Pharmactive Biotech Products for oral dietary supplements targeting eye health, particularly age-related macular degeneration and related ocular disorders. It is a standardized botanical small molecule product derived from *Crocus sativus* L. stigmas and manufactured using the proprietary AFF ON Cool-Tech extraction process, with specification for Crocuvisalides content including crocins and kaempferol glycosides. Its proposed mechanism is antioxidant and anti-inflammatory support of retinal and macular function, with reported use to support visual acuity, retinal health, and reduction of retinal inflammation. It is marketed as a dietary supplement ingredient rather than an FDA-approved pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Affron EYE.